CYP26C1, which is involved in retinoic acid metabolism that is crucial for neuronal development, may contribute to AD risk, as abnormal retinoid metabolism has been implicated in neuropsychiatric disorders [44]. This evidence concerns the gene CYP26C1 and Alzheimer disease.